The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
Tiollais, P., Pourcel, C., & Dejean, A. (1985) · Nature · doi:10.1038/317489a0 · Cited by 1,205
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L., & Palmiter, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90770-8 · Cited by 697
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice
Vogel, J., Hinrichs, S. H., Reynolds, R. K., Luciw, P. A., & Jay, G. (1988) · Nature · doi:10.1038/335606a0 · Cited by 526
Self-citationThe tat Gene of Human T-Lymphotropic Virus Type 1 Induces Mesenchymal Tumors in Transgenic Mice
Nerenberg, M., Hinrichs, S. H., Reynolds, R. K., Khoury, G., & Jay, G. (1987) · Science · doi:10.1126/science.2888190 · Cited by 510
Self-citationExocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice
Green, J. E., Hinrichs, S. H., Vogel, J., & Jay, G. (1989) · Nature · doi:10.1038/341072a0 · Cited by 331
Self-citationtrans-activation of viral enhancers by the hepatitis B virus X protein
Spandau, D. F., & Lee, C. H. (1988) · Journal of Virology · doi:10.1128/jvi.62.2.427-434.1988 · Cited by 315
A Transgenic Mouse Model of the Chronic Hepatitis B Surface Antigen Carrier State
Chisari, F. V., Pinkert, C. A., Milich, D. R., Filippi, P., McLachlan, A., Palmiter, R. D., & Brinster, R. L. (1985) · Science · doi:10.1126/science.3865369 · Cited by 290
de Thé, H., Marchio, A., Tiollais, P., & Dejean, A. (1987) · Nature · doi:10.1038/330667a0 · Cited by 284
Cited by
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,357
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
zur Hausen, H. (1991) · Science · doi:10.1126/science.1659743 · Cited by 784
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
High-level hepatitis B virus replication in transgenic mice
Guidotti, L. G., Matzke, B., Schaller, H., & Chisari, F. V. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6158-6169.1995 · Cited by 642
Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Torbenson, M., & Thomas, D. L. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00345-6 · Cited by 533
The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-21 · Cited by 513
Self-citationNuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Belloni, L., Pollicino, T., De Nicola, F., Guerrieri, F., Raffa, G., Fanciulli, M., Raimondo, G., & Levrero, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908365106 · Cited by 498
The Enigmatic X Gene of Hepatitis B Virus
Bouchard, M. J., & Schneider, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12725-12734.2004 · Cited by 498
Woodchuck hepatitis virus X protein is required for viral infection in vivo
Zoulim, F., Saputelli, J., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2026-2030.1994 · Cited by 453
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yang, Y., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 449
Okuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Chen, X., & Calvisi, D. F. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.12.002 · Cited by 434
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Viral Control of Mitochondrial Apoptosis
Galluzzi, L., Brenner, C., Morselli, E., Touat, Z., & Kroemer, G. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000018 · Cited by 427
Mechanisms of HBV-related hepatocarcinogenesis
Neuveut, C., Wei, Y., & Buendia, M. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.033 · Cited by 421
Benn, J., & Schneider, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10350 · Cited by 418
Repopulation of Mouse Liver With Human Hepatocytes And In Vivo Infection With Hepatitis B Virus
Dandri, M., Burda, M. R., Török, E., Pollok, J. M., Iwanska, A., Sommer, G., Rogiers, X., Rogler, C. E., Gupta, S., Will, H., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.23314 · Cited by 405
Historical review of the causes of cancer
Blackadar, C. B. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.54 · Cited by 389
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
Kekulé, A. S., Lauer, U., Weiss, L., Luber, B., & Hofschneider, P. H. (1993) · Nature · doi:10.1038/361742a0 · Cited by 369
Functional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Self-citationDu, Y., Kong, G., You, X., Zhang, S., Zhang, T., Gao, Y., Ye, L., & Zhang, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.342113 · Cited by 360
Huang, J., Wang, Y., Guo, Y., & Sun, S. (2010) · Hepatology · doi:10.1002/hep.23660 · Cited by 342
Infectious agents and cancer: criteria for a causal relation
Pagano, J. S., Blaser, M., Buendia, M.-A., Damania, B., Khalili, K., Raab-Traub, N., & Roizman, B. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.009 · Cited by 337
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Huang, J.-F., Guo, Y.-J., Zhao, C.-X., Yuan, S.-X., Wang, Y., Tang, G.-N., Zhou, W.-P., & Sun, S.-H. (2013) · Hepatology · doi:10.1002/hep.26195 · Cited by 323
Hepatitis B virus X protein: a multifunctional viral regulator
Murakami, S. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170027 · Cited by 322
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Aberrant Epigenetic Modifications in Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
Park, I. Y., Sohn, B. H., Yu, E., Suh, D. J., Chung, Y., Lee, J., Surzycki, S. J., & Lee, Y. I. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.034 · Cited by 320
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
Schulze, K., Nault, J.-C., & Villanueva, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.035 · Cited by 317
Medical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314
Hepatitis B virus and hepatocellular carcinoma
Arbuthnot, P., & Kew, M. (2001) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2001.iep178.x · Cited by 306
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
The landscape of viral expression and host gene fusion and adaptation in human cancer
Tang, K.-W., Alaei-Mahabadi, B., Samuelsson, T., Lindh, M., & Larsson, E. (2013) · Nature Communications · doi:10.1038/ncomms3513 · Cited by 301
Knight, B., Yeoh, G. C. T., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 301
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α
Su, F., & Schneider, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8744 · Cited by 300
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.
Benn, J., & Schneider, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11215 · Cited by 288
Chung, T., Lee, Y., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1429fje · Cited by 288
Self-citationHigh-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T., & Kurokawa, K. (1994) · Hepatology · doi:10.1002/hep.1840190403 · Cited by 287
Self-citationMolecular functions and biological roles of hepatitis B virus x protein
Tang, H., Oishi, N., Kaneko, S., & Murakami, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00299.x · Cited by 282
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280
Kanda, T., Goto, T., Hirotsu, Y., Moriyama, M., & Omata, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061358 · Cited by 280
Kew, M. C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06546.x · Cited by 279
Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0321 · Cited by 276
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Hepatitis B virus-induced oncogenesis
Lupberger, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.74 · Cited by 267
Truant, R., Antunovic, J., Greenblatt, J., Prives, C., & Cromlish, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1851-1859.1995 · Cited by 255
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J. W., & Oshimura, M. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00329-9 · Cited by 174
Yu, Z., Feng, H., Zhuo, Y., Li, M., Zhu, X., Huang, L., Zhang, X., Zhou, Z., Zheng, C., Jiang, Y., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00546-0 · Cited by 27
“HBx-transgenic mice can simulate human HBV carriers, thus providing an ideal model for studying HBx-induced molecular events that are responsible for HCC development [34].”
Background
Metadata
- Authors
- Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G.
- Venue
- Nature
- Published
- 1991-05
- Volume
- 351
- Issue
- 6324
- Pages
- 317-320
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986150533
- Cited by
- 1,158
- References
- 20
- FWCI
- 39.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.